ADUS vs. USPH: Which Stock Is the Better Value Option?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • Dec 30, 2025

Addus HomeCare (ADUS) Upgraded to Buy: Here's What You Should Know

Addus HomeCare (ADUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research • Dec 24, 2025

These 3 Medical Stocks Have Wall Street's Bullish Vote for 2026

COR, ADUS and SEM earn bullish analyst support for 2026 as AI adoption, home care demand and facility expansion fuel medical sector growth.

Zacks Investment Research • Dec 24, 2025

ADUS or USPH: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • Dec 11, 2025

Here is Why Growth Investors Should Buy Addus HomeCare (ADUS) Now

Addus HomeCare (ADUS) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Investment Research • Nov 24, 2025

Addus HomeCare Corporation (ADUS) Presents at UBS Global Healthcare Conference 2025 Transcript

Addus HomeCare Corporation ( ADUS ) UBS Global Healthcare Conference 2025 November 12, 2025 10:15 AM EST Company Participants R. Allison - CEO & Chairman of the Board Brian Poff - CFO, Executive VP, Secretary & Treasurer Heather Dixon - President & COO Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Presentation Albert Rice UBS Investment Bank, Research Division I think we'll get going with our next presenter here, Addus Healthcare -- or Home care, rather, very pleased to have them participating in our conference this year.

Seeking Alpha • Nov 12, 2025

Addus HomeCare to Participate in Upcoming Investor Conferences in November

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced its participation at the following investor conferences in November: 2025 UBS Global Healthcare Conference in Palm Beach Gardens, Florida. Dirk Allison, Chairman and Chief Executive Officer, Heather Dixon, President and Chief Operating Officer and Brian Poff, Executive Vice President and Chief Financial Officer, will present at 9:15 a.m. Central Time / 10:15 a.m. Eastern.

Business Wire • Nov 5, 2025

Addus HomeCare Corporation (ADUS) Q3 2025 Earnings Call Transcript

Addus HomeCare Corporation ( ADUS ) Q3 2025 Earnings Call November 4, 2025 9:00 AM EST Company Participants R. Allison - CEO & Chairman of the Board Brian Poff - CFO, Executive VP, Secretary & Treasurer Heather Dixon - President & COO Conference Call Participants Dru Anderson - Corporate Communications, Inc. Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Brian Tanquilut - Jefferies LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Albert Rice - UBS Investment Bank, Research Division Jared Haase - William Blair & Company L.L.C.

Seeking Alpha • Nov 4, 2025

Addus HomeCare Announces Third Quarter 2025 Financial Results

FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the third quarter and nine months ended September 30, 2025. Third Quarter 2025 Highlights: Net Service Revenues Grow 25.0% to $362.3 Million Net Income of $22.8 Million, or $1.24 per Diluted Share Adjusted Net Income per Diluted Share Increases 20.0% year-over-year to $1.56 Adjusted EBITDA Increases 31.6% year-over-year to $45.1 Million Cash Flow.

Business Wire • Nov 3, 2025

Addus HomeCare (ADUS) Beats Q3 Earnings and Revenue Estimates

Addus HomeCare (ADUS) came out with quarterly earnings of $1.56 per share, beating the Zacks Consensus Estimate of $1.53 per share. This compares to earnings of $1.3 per share a year ago.

Zacks Investment Research • Nov 4, 2025